prIME Oncology Awarded ACCME Accreditation with Commendation

Top Quote Accredited evidence-based education bridges gap between oncology innovations and integration into clinical practice. End Quote
  • (1888PressRelease) March 29, 2017 - Atlanta, GA - Oncologists and hematologists rely on accredited continuing medical education (CME) as an important support system to assist in improving their clinical practice and care of patients. The Accreditation Council for Continuing Medical Education (ACCME®) is the authority responsible for accrediting institutions that offer CME to physicians and other healthcare professionals. prIME Oncology is a leading global provider of Independent Medical Education in oncology and hematology and has now received accreditation with commendation from ACCME-the highest distinction awarded by the regulatory body. prIME Oncology's full portfolio of educational activities provide expert guidance that cancer fighters need to support the best possible treatment decisions for their patients.

    The importance of ACCME accreditation with commendation
    Accredited CME helps health professionals solve real-world problems, advance team-based care, and achieve their institutions' goals. Continuing medical education activities cover the full range of topics important to the professional development of healthcare practitioners and assists them in solving real-world problems. The purpose of the ACCME accreditation requirements is to set expectations for accredited providers that ensure CME is independent, based on valid content, and contributes to healthcare improvement for patients and their communities. The ACCME system employs a rigorous process for evaluating institutions' CME programs according to standards that reflect the values of the educator community and aim to accelerate learning. With a 6-year term, accreditation with commendation is awarded to institutions that demonstrate complete regulatory compliance with all accreditation policies and have successfully engaged in a framework of quality improvement. The ACCME commended prIME Oncology for meeting the ACCME's accreditation with commendation requirements and for demonstrating that prIME Oncology is a learning organization and a change agent for the physicians and patients they serve.

    Access to a broad portfolio of evidence-based oncology education
    The fields of oncology and hematology are evolving at an extreme pace relative to other areas of medicine. The expeditious nature of new developments in the treatment of cancer creates an immense need for continuing education of healthcare providers and creates a significant level of complexity for those organizations charged with providing that education. The commendation level of accreditation underscores prIME Oncology's commitment to providing premiere educational opportunities that have been shown to impact clinical practice and, ultimately, the outcomes of patients with cancer.

    Nathan Kelly PhD, president of prIME Oncology commented, "With more complex treatment concepts and options emerging nearly every month, our educational resources are a necessity for healthcare professionals in their effort to fully understand new therapeutic advances and integrate them into daily clinical practice. Every prIME Oncology educational activity provides our learners with opportunities to improve their clinical competency and turn knowledge into powerful interventions that improve patient care. We are proud to have been awarded accreditation with commendation from the ACCME as we enthusiastically continue our efforts to provide impactful education to oncologists and hematologists on the front lines worldwide."

    About prIME Oncology
    prIME Oncology is a global leading provider of independent, ACCME-accredited with commendation medical education in oncology and hematology. prIME Oncology develops educational activities that translate emerging scientific and clinical advances into insights that improve patient outcomes. prIME Oncology's evidence-based educational activities translate new clinical innovations into practical guidance for oncologists and hematologists. prIME Oncology is committed to improving patients' treatment by deepening healthcare professionals' knowledge and sharpening their decision-making skills via live and on-demand educational activities and peer-reviewed publications. With the oncology landscape evolving constantly, prIME Oncology's educational activities help make new advances accessible, meaningful, and useful for healthcare professionals. prIME Oncology is an Aptitude Health company.

    Visit for more information.

  • FB Icon Twitter Icon In-Icon
Contact Information